
Valarie E. Bertoglio
Examiner (ID: 294, Phone: (571)272-0725 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632 |
| Total Applications | 1278 |
| Issued Applications | 615 |
| Pending Applications | 184 |
| Abandoned Applications | 505 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11936712
[patent_doc_number] => 20170240861
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-24
[patent_title] => 'HUMAN PLURIPOTENT STEM CELL DERIVED ENDOCARDIAL ENDOTHELIUM'
[patent_app_type] => utility
[patent_app_number] => 15/437786
[patent_app_country] => US
[patent_app_date] => 2017-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 32838
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15437786
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/437786 | Human pluripotent stem cell derived endocardial endothelium | Feb 20, 2017 | Issued |
Array
(
[id] => 17436119
[patent_doc_number] => 11261433
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-01
[patent_title] => Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/071094
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 15
[patent_no_of_words] => 16532
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071094
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071094 | Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof | Jan 30, 2017 | Issued |
Array
(
[id] => 17756360
[patent_doc_number] => 11396644
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof
[patent_app_type] => utility
[patent_app_number] => 16/072610
[patent_app_country] => US
[patent_app_date] => 2017-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 15551
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 220
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072610
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072610 | Method for promoting differentiation of pluripotent stem cells by reducing undifferentiated state thereof | Jan 30, 2017 | Issued |
Array
(
[id] => 14564007
[patent_doc_number] => 20190209610
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => INDUCED PLURIPOTENT STEM CELLS PRODUCED FROM DENDRITIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/071414
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13686
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071414
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071414 | Induced pluripotent stem cells produced from dendritic cells | Jan 25, 2017 | Issued |
Array
(
[id] => 11620013
[patent_doc_number] => 20170130201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-11
[patent_title] => 'COMPOSITIONS AND METHODS OF PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 15/413931
[patent_app_country] => US
[patent_app_date] => 2017-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12087
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15413931
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/413931 | Platelet-rich plasma compositions and methods of preparation | Jan 23, 2017 | Issued |
Array
(
[id] => 13778591
[patent_doc_number] => 20190002834
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => METHOD FOR PREPARING POPULATION OF STEM CELL SPHEROIDS
[patent_app_type] => utility
[patent_app_number] => 16/067103
[patent_app_country] => US
[patent_app_date] => 2016-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067103
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/067103 | METHOD FOR PREPARING POPULATION OF STEM CELL SPHEROIDS | Dec 27, 2016 | Abandoned |
Array
(
[id] => 14498087
[patent_doc_number] => 20190192698
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => A METHOD FOR OBTAINING INDICATOR SIGNALS FROM A CELL
[patent_app_type] => utility
[patent_app_number] => 16/064814
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13706
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064814
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/064814 | A METHOD FOR OBTAINING INDICATOR SIGNALS FROM A CELL | Dec 21, 2016 | Abandoned |
Array
(
[id] => 16756901
[patent_doc_number] => 10975441
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => R2R1/2 in diagnosis and therapy
[patent_app_type] => utility
[patent_app_number] => 15/383085
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 53
[patent_no_of_words] => 16771
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383085
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383085 | R2R1/2 in diagnosis and therapy | Dec 18, 2016 | Issued |
Array
(
[id] => 11742920
[patent_doc_number] => 20170196992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-13
[patent_title] => 'METHODS AND COMPOSITIONS FOR ENGINEERING IMMUNITY'
[patent_app_type] => utility
[patent_app_number] => 15/357772
[patent_app_country] => US
[patent_app_date] => 2016-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 25782
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15357772
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/357772 | Methods and compositions for engineering immunity | Nov 20, 2016 | Issued |
Array
(
[id] => 11492896
[patent_doc_number] => 20170067081
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 15/354604
[patent_app_country] => US
[patent_app_date] => 2016-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 34878
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15354604
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/354604 | NUCLEIC ACID CONSTRUCTS ENCODING REPROGRAMMING FACTORS LINKED BY SELF-CLEAVING PEPTIDES | Nov 16, 2016 | Abandoned |
Array
(
[id] => 12522144
[patent_doc_number] => 10004211
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-06-26
[patent_title] => Humanized IL-6 and IL-6 receptor
[patent_app_type] => utility
[patent_app_number] => 15/350739
[patent_app_country] => US
[patent_app_date] => 2016-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10653
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15350739
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/350739 | Humanized IL-6 and IL-6 receptor | Nov 13, 2016 | Issued |
Array
(
[id] => 13577277
[patent_doc_number] => 20180340187
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-29
[patent_title] => METHODS OF TREATING MUSCULAR DYSTROPHY
[patent_app_type] => utility
[patent_app_number] => 15/775566
[patent_app_country] => US
[patent_app_date] => 2016-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17157
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775566
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775566 | Methods of treating muscular dystrophy | Nov 10, 2016 | Issued |
Array
(
[id] => 16351231
[patent_doc_number] => 10791721
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => WW homogametic male decapod crustacean and methods of using the same
[patent_app_type] => utility
[patent_app_number] => 15/775259
[patent_app_country] => US
[patent_app_date] => 2016-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 28
[patent_no_of_words] => 13161
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15775259
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/775259 | WW homogametic male decapod crustacean and methods of using the same | Nov 9, 2016 | Issued |
Array
(
[id] => 13151603
[patent_doc_number] => 10092504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Use of cellular extracts for skin rejuvenation
[patent_app_type] => utility
[patent_app_number] => 15/343984
[patent_app_country] => US
[patent_app_date] => 2016-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 22
[patent_no_of_words] => 40261
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15343984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/343984 | Use of cellular extracts for skin rejuvenation | Nov 3, 2016 | Issued |
Array
(
[id] => 13519453
[patent_doc_number] => 20180311269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => TARGETED CANCER THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/772134
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -88
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15772134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/772134 | Targeted cancer therapy | Oct 27, 2016 | Issued |
Array
(
[id] => 12681781
[patent_doc_number] => 20180119093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => Method of Progenitor Cell Isolation From Different Organs by Natural Destruction of Extracellular Matrix
[patent_app_type] => utility
[patent_app_number] => 15/338229
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15338229
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/338229 | Method of progenitor cell isolation from different organs by natural destruction of extracellular matrix | Oct 27, 2016 | Issued |
Array
(
[id] => 15496841
[patent_doc_number] => 20200048609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => METHODS AND COMPOSITIONS FOR GENERATING HEMATOPOIETIC CELLS
[patent_app_type] => utility
[patent_app_number] => 16/343617
[patent_app_country] => US
[patent_app_date] => 2016-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12390
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16343617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/343617 | Methods and compositions for generating hematopoietic cells | Oct 20, 2016 | Issued |
Array
(
[id] => 15576465
[patent_doc_number] => 10578608
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2020-03-03
[patent_title] => Tools to detect, track and target cancer cells in vivo
[patent_app_type] => utility
[patent_app_number] => 15/294492
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 345
[patent_no_of_words] => 58592
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15294492
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/294492 | Tools to detect, track and target cancer cells in vivo | Oct 13, 2016 | Issued |
Array
(
[id] => 19809681
[patent_doc_number] => 12241053
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Modulation of novel immune checkpoint targets
[patent_app_type] => utility
[patent_app_number] => 15/767074
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 57
[patent_no_of_words] => 105504
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15767074
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/767074 | Modulation of novel immune checkpoint targets | Oct 6, 2016 | Issued |
Array
(
[id] => 13037907
[patent_doc_number] => 10041077
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-07
[patent_title] => DNA vectors, transposons and transposases for eukaryotic genome modification
[patent_app_type] => utility
[patent_app_number] => 15/287624
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39314
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15287624
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/287624 | DNA vectors, transposons and transposases for eukaryotic genome modification | Oct 5, 2016 | Issued |